Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HMGCR | P04035 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | CPT2 | P23786 | 1/20 | 0.32 |
| ▸ | ACLY | P53396 | 1/20 | 0.32 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.31 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7999396 | 0.98 | TDP1 (0.40) | TDP1SLC22A6GABRR1LMNASMN1; SMN2 | |
| SCHEMBL396503 | 0.98 | TDP1 (0.40) | TDP1SLC22A6GABRR1LMNASMN1; SMN2 | |
| SCHEMBL465794 | 0.78 | TDP1 (0.40) | TDP1SLC22A6GABRR1LMNASMN1; SMN2 | |
| SCHEMBL3336391 | 0.76 | TDP1 (0.39) | TDP1SLC22A6GABRR1LMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL28132580 | 0.76 | SLC22A6 (0.35) | TDP1SLC22A6GABRR1LMNASMN1; SMN2 | |
| SCHEMBL271763 | 0.76 | TDP1 (0.39) | TDP1SLC22A6GABRR1LMNASMN1; SMN2 | |
| SCHEMBL9805121 | 0.75 | TDP1 (0.37) | TDP1SLC22A6GABRR1LMNASMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL10701836 | 0.75 | TDP1 (0.42) | TDP1SLC22A6GABRR1LMNASMN1; SMN2 | |
| SCHEMBL9372723 | 0.74 | TDP1 (0.46) | TDP1SLC22A6GABRR1LMNASMN1; SMN2 | |
| SCHEMBL28726922 | 0.73 | SLC22A6 (0.37) | TDP1SLC22A6GABRR1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113874476-A | Catalyst for reactivation hydrotreating for sulfur reduction | 赢创运营有限公司 | 2021-12-31 | — | — | CN | disclosed |
| US-20140216478-A1 | MULTILAYERED NONWOVEN FABRIC WITH ANTI-ALLERGIC EFFECT | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-08-07 | — | — | US | disclosed |
| EP-2721208-A2 | MULTILAYERED NONWOVEN FABRIC WITH ANTI-ALLERGIC EFFECT | 3M Innovative Properties Company (US) | 2014-04-23 | — | — | EP | disclosed |
| WO-2012177648-A2 | MULTILAYERED NONWOVEN FABRIC WITH ANTI-ALLERGIC EFFECT | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-12-27 | — | — | WO | disclosed |
| US-20120264942-A1 | METHOD FOR SCREENING OSTEOPONTIN INHIBITOR AND INHIBITOR OBTAINED FROM THE METHOD | INNOPHARMASCREEN, INC. (KR) | 2012-10-18 | — | — | US | disclosed |
| EP-2431738-A1 | METHOD FOR SCREENING OSTEOPONTIN INHIBITOR AND INHIBITOR PREPARED THEREBY | Innopharmascreen Inc. (KR) | 2012-03-21 | — | — | EP | disclosed |
| EP-1638546-A1 | USE OF ALPHA-KETOGLUTARIC ACID FOR THE TREATMENT OF MALNUTRITION OR HIGH PLASMA GLUCOSE CONDITION | Essentys AB (SE) | 2006-03-29 | — | — | EP | disclosed |
| WO-2005002567-A1 | USE OF ALPHA-KETOGLUTARIC ACID FOR THE TREATMENT OF MALNUTRITION OR HIGH PLASMA GLUCOSE CONDITION | ESSENTYS AB (SE) | 2005-01-13 | — | — | WO | disclosed |
| EP-0921726-A4 | STOMACH-ACTION MOLLUSCICIDES | YOUNG COLIN LESLIE (AU) | 2000-06-21 | — | — | EP | disclosed |
| US-5985508-A | SILVER HALIDE EMULSIONS ON SUPPORTS WITH COLLOID LAYERS, GOLD SULFUR SENSITIZATION AND TREATMENT WITH HYDRAZIDES | FUJI PHOTO FILM CO., LTD. (JP) | 1999-11-16 | — | — | US | disclosed |
| EP-0921726-A1 | STOMACH-ACTION MOLLUSCICIDES | Young, Colin Leslie (AU) | 1999-06-16 | — | — | EP | disclosed |
| US-5888694-A | MATERIAL CONTAINING COMPOUND HAVING ADSORPTION ACCELERATING GROUP AND QUATERNIZED NITROGEN-CONTAINING HETEROCYCLIC RING;FORMING HIGH CONTRAST IMAGES | FUJI PHOTO FILM CO., LTD. (JP) | 1999-03-30 | — | — | US | disclosed |
| US-5759758-A | Silver halide photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1998-06-02 | — | — | US | disclosed |
| WO-1997026789-A1 | STOMACH-ACTION MOLLUSCICIDES | YOUNG COLIN LESLIE (AU) | 1997-07-31 | — | — | WO | disclosed |
| US-5356760-A | Silver chlorobromide emulsion containing resorcinol-based or aminophenol-based coupler, gelatin in specifed coating weight, on support | KONICA CORPORATION (JP) | 1994-10-18 | — | — | US | disclosed |
| EP-0568777-A1 | Silver halide photographic light-sensitive material | KONICA CORPORATION (JP) | 1993-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264942-A1 | METHOD FOR SCREENING OSTEOPONTIN INHIBITOR AND INHIBITOR OBTAINED FROM THE METHOD | SOST, ACP3, PTH1R | TDP1 3404/4885SLC22A6 2165/4885GABRR1 4284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.